Tracking a new prostate cancer Drug's Real-World impact in china
NCT ID NCT07290270
Summary
This study aims to understand how well a targeted radioactive drug works for men with advanced prostate cancer that has spread, in real-world hospital settings across China. It will follow about 170 patients who are already scheduled to receive this treatment, observing their health outcomes and quality of life for up to a year. The goal is to gather practical information on how the drug performs outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGShanghai, Shanghai Municipality, 201321, China
Conditions
Explore the condition pages connected to this study.